Chemotherapy and Targeted Therapy

Biopharma Industry Update: Clinical Breakthroughs, Manufacturing Overhauls, and Strategic Portfolio Shifts

• Chemotherapy and Targeted Therapy

Biopharma Industry Update: Clinical Breakthroughs, Manufacturing Overhauls, and Strategic Portfolio Shifts

Nana Wu May 9, 2026 0

Published May 6, 2026 | By Ben Fidler The biopharmaceutical sector is currently navigating a period of...

Read More Read more about Biopharma Industry Update: Clinical Breakthroughs, Manufacturing Overhauls, and Strategic Portfolio Shifts

Precision Medicine Breakthrough: New AI Framework Optimizes Drug Combinations for Lung Adenocarcinoma

• Chemotherapy and Targeted Therapy

Precision Medicine Breakthrough: New AI Framework Optimizes Drug Combinations for Lung Adenocarcinoma

Dwi Wanna May 9, 2026 0

In a significant leap forward for computational oncology, researchers from Istanbul Topkapi University have unveiled a novel,...

Read More Read more about Precision Medicine Breakthrough: New AI Framework Optimizes Drug Combinations for Lung Adenocarcinoma

Bayer Re-enters M&A Arena with $2.45 Billion Acquisition of Perfuse Therapeutics

• Chemotherapy and Targeted Therapy

Bayer Re-enters M&A Arena with $2.45 Billion Acquisition of Perfuse Therapeutics

Neng Nana May 9, 2026 0

By Delilah Alvarado | May 6, 2026 In a significant strategic pivot that signals a return to...

Read More Read more about Bayer Re-enters M&A Arena with $2.45 Billion Acquisition of Perfuse Therapeutics

New Frontier in Dermatology: Quercetin-Loaded Nano-Emulsions Offer Breakthrough Defense Against Chronic Sun Damage

• Chemotherapy and Targeted Therapy

New Frontier in Dermatology: Quercetin-Loaded Nano-Emulsions Offer Breakthrough Defense Against Chronic Sun Damage

Raul Delapena Setiawan May 9, 2026 0

Main Facts: A New Mechanism for Skin Resilience Skin photoaging—the cumulative, degenerative process triggered by prolonged exposure...

Read More Read more about New Frontier in Dermatology: Quercetin-Loaded Nano-Emulsions Offer Breakthrough Defense Against Chronic Sun Damage

Clinical Setback: Entrada Therapeutics Faces Market Skepticism Following Latest DMD Trial Data

• Chemotherapy and Targeted Therapy

Clinical Setback: Entrada Therapeutics Faces Market Skepticism Following Latest DMD Trial Data

Rifan Muazin May 9, 2026 0

In the high-stakes arena of rare disease drug development, perception is often as volatile as the underlying...

Read More Read more about Clinical Setback: Entrada Therapeutics Faces Market Skepticism Following Latest DMD Trial Data

Unlocking the Hemostatic Paradox: How TFPI Levels Drive Coagulation Shifts in Pediatric IBD

• Chemotherapy and Targeted Therapy

Unlocking the Hemostatic Paradox: How TFPI Levels Drive Coagulation Shifts in Pediatric IBD

Ali Ikhwan May 9, 2026 0

In the complex landscape of pediatric medicine, few conditions present as many systemic challenges as Inflammatory Bowel...

Read More Read more about Unlocking the Hemostatic Paradox: How TFPI Levels Drive Coagulation Shifts in Pediatric IBD

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

• Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0

In a significant milestone for the biotechnology industry, Odyssey Therapeutics has officially made its debut on the...

Read More Read more about Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Revolutionizing Antibacterial Discovery: The 5F-MDL Strategy

• Chemotherapy and Targeted Therapy

Revolutionizing Antibacterial Discovery: The 5F-MDL Strategy

Sagoh May 9, 2026 0

The global crisis of antimicrobial resistance (AMR) has long demanded a shift in how we identify new...

Read More Read more about Revolutionizing Antibacterial Discovery: The 5F-MDL Strategy

The Borderless Frontier: Navigating the High-Stakes Complexity of Global Pharmaceutical IP

• Chemotherapy and Targeted Therapy

The Borderless Frontier: Navigating the High-Stakes Complexity of Global Pharmaceutical IP

Evan Lee Salim May 9, 2026 0

In the modern pharmaceutical landscape, the journey of a life-saving therapy is rarely a linear path contained...

Read More Read more about The Borderless Frontier: Navigating the High-Stakes Complexity of Global Pharmaceutical IP

Biopharma Industry Update: Regulatory Breakthroughs, Leadership Transitions, and Strategic Capital Injections

• Chemotherapy and Targeted Therapy

Biopharma Industry Update: Regulatory Breakthroughs, Leadership Transitions, and Strategic Capital Injections

Pevita Pearce May 8, 2026 0

By Ben Fidler | May 8, 2026 The biopharmaceutical landscape continues to evolve at a breakneck pace,...

Read More Read more about Biopharma Industry Update: Regulatory Breakthroughs, Leadership Transitions, and Strategic Capital Injections